MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
TFX stock logo

TFX

Teleflex Incorporated

$117.81
-0.61
 (-0.52%)
Exchange:  NYSE
Market Cap:  5.207B
Shares Outstanding:  31.667M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Instruments & Supplies
   
CEO:  Stuart A. Randle
Full Time Employees:  14100
Address: 
550 East Swedesford Road
Wayne
PA
19087-1603
US
Website:  https://www.teleflex.com
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/01 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,974,4893,047,3241,992,713
Gross Profit1,646,9311,702,6791,120,754
EBITDA761,212433,623302,514
Operating Income506,313151,013255,804
Net Income356,32869,675-905,640

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets7,532,5467,097,9146,947,239
Total Liabilities3,091,5582,819,7743,822,471
Total Stockholders Equity4,440,9884,278,1403,124,768
Total Debt1,926,3721,755,025184,210
Cash and Cash Equivalents222,848290,188378,564

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow510,638635,73996,682
Capital Expenditure-91,442-126,4340
Free Cash Flow419,196509,30596,682
Net Income356,32869,675-905,640
Net Change in Cash-69,186104,80275,031

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)2,821,317.636Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)2,858,246.194Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)2,835,000Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)629,570.492Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)637,811.014Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)632,623.680Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)579,986.211Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)589,869.768Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)583,648.213Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)911,973.727Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)923,910.658Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)916,396.467Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)13.050Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)13.190Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)12.970Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
3.047B  ?P/S
 (TTM)
: 
1.96
?Net Income
 (TTM)
: 
69.675M  ?P/E
 (TTM)
: 
-6.43
?Enterprise Value
 (TTM)
: 
8.148B  ?EV/FCF
 (TTM)
: 
33.2
?Dividend Yield
 (TTM)
: 
0.01  ?Payout Ratio
 (TTM)
: 
-0.07
?ROE
 (TTM)
: 
-0.24  ?ROIC
 (TTM)
: 
0.04
?Net Debt
 (TTM)
: 
1.482B  ?Debt/Equity
 (TTM)
: 
0.87
?P/B
 (TTM)
: 
1.86  ?Current Ratio
 (TTM)
: 
2.54

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
17.53Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates TFX intrinsic value between $156.22 – $159.13 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate TFX Intrinsic Value

Common questions about TFX valuation

Is Teleflex Incorporated (TFX) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Teleflex Incorporated (TFX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is TFX a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether TFX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is TFX’s P/E ratio?

You can see TFX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for TFX?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is TFX a good long-term investment?

Whether TFX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

TFX

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.52
MARKETSnap

Trading Metrics:

Open: 117.38   Previous Close: 118.42
Day Low: 115.33   Day High: 119.1
Year Low: 100.18   Year High: 138.93
Price Avg 50: 110.28   Price Avg 200: 117.72
Volume: 406880   Average Volume: 923024

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Teleflex Incorporated Investigated by the Portnoy Law Firm
17-04-2026 09:00
Teleflex Incorporated Investigated by the Portnoy Law Firm
Irenic Comments on Teleflex's Announcement That It Is Open to Strategic Alternatives
27-03-2026 14:31
Irenic Comments on Teleflex's Announcement That It Is Open to Strategic Alternatives
Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution
27-03-2026 12:57
Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution
Teleflex Incorporated (NYSE:TFX) Given Average Recommendation of “Hold” by Brokerages
20-03-2026 03:00
Teleflex Incorporated (NYSE:TFX) Given Average Recommendation of “Hold” by Brokerages
TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market
27-02-2026 08:47
TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market
Teleflex Incorporated (TFX) Q4 2025 Earnings Call Transcript
26-02-2026 17:08

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read